CSS Drop Down Menu by

Publications → Papers → References

Nutraceuticals molecular targets (III) - targeting protein receptors with polyphenols as new anti-obesity therapies. Micol, V., Encinar, J.A. and Herranz-López, M.. 2017. Agro FOOD Industry Hi Tech - vol. 28(5) - September/October 2017.

  1. Herranz-Lopez M, Olivares-Vicente M, Encinar JA, Barrajon-Catalan E, Segura-Carretero A, Joven J, Micol V: Multi-Targeted Molecular Effects of Hibiscus sabdariffa Polyphenols: An Opportunity for a Global Approach to Obesity. Nutrients 2017, 9.
  2. Lalloyer F, Staels B: Fibrates, glitazones, and peroxisome proliferatoractivated receptors. Arterioscler Thromb Vasc Biol 2010, 30:894-899.
  3. Kawamatsu Y, Saraie T, Imamiya E, Nishikawa K, Hamuro Y: Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives. Arzneimittelforschung 1980, 30:454-459.
  4. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988, 37:1549-1558.
  5. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
  6. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995, 270:12953-12956.
  7. Johns E, McKay G, Fisher M: Glitazones (thiazolidinediones). Br J Cardiol 2017, 24:113-116.
  8. Rull A, Geeraert B, Aragones G, Beltran-Debon R, Rodriguez-Gallego E, Garcia-Heredia A, Pedro-Botet J, Joven J, Holvoet P, Camps J: Rosiglitazone and Fenofibrate Exacerbate Liver Steatosis in a Mouse Model of Obesity and Hyperlipidemia. A Transcriptomic and Metabolomic Study. J Proteome Res 2014.
  9. Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, et al: Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a review. Biochem Pharmacol 2014, 92:73-89.
  10. Encinar JA, Fernandez-Ballester G, Galiano-Ibarra V, Micol V: In silico approach for the discovery of new PPARgamma modulators among plant-derived polyphenols. Drug Des Devel Ther 2015, 9:5877-5895.
  11. Garcia-Vallve S, Guasch L, Tomas-Hernandez S, del Bas JM, Ollendorff V, Arola L, Pujadas G, Mulero M: Peroxisome Proliferator-Activated Receptor gamma (PPARgamma) and Ligand Choreography: Newcomers Take the Stage. J Med Chem 2015, 58:5381-5394.
  12. Dominguez-Avila JA, Gonzalez-Aguilar GA, Alvarez-Parrilla E, de la Rosa LA: Modulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets. Int J Mol Sci 2016, 17.
  13. Herranz-Lopez M, Barrajon-Catalan E, Segura-Carretero A, Menendez JA, Joven J, Micol V: Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms. Phytomedicine 2015, 22:605-614.
  14. Higgins LS, Depaoli AM: Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. Am J Clin Nutr 2010, 91:267S-272S.